[paula_w]

Am I closer to understanding why people go berserk after reading this paragraph in an article about Amgen? I think so. But if ever really get to the point of going berserk... I won't be able to move to do it.


Does this make your blood boil or what?

In 1994, Amgen made its first acquisition - Synergen Inc., for $262 million through a cash tender offer. The acquisition gave Amgen the patent right to synthetic GDNF or Glial cell line-derived neurotrophic factor developed by Synergen. GDNF was thought to hold great promise for treating Parkinson's disease. However, the much-touted GDNF trial turned out to be a bust as the compound failed to demonstrate any clinical improvement after six months of use and on September 1, 2004, Amgen halted all clinical trials of GDNF.


Amgen - Healthy Or Anemic
RTT News - Williamsville,NY,USA
The acquisition gave Amgen the patent right to synthetic GDNF or Glial cell line-derived neurotrophic factor developed by Synergen. GDNF was thought to hold ...